Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Medifast Inc.

    NYSE: MED · Real-Time Price · USD
    13.54
    0.56 (4.31%)
    At close: Jun 16, 2025, 3:59 PM
    13.13
    -3.03%
    Pre-market: Jun 17, 2025, 05:05 AM EDT

    Medifast Statistics

    Share Statistics

    Medifast has 10.99M shares outstanding. The number of shares has increased by 0.01% in one year.

    Shares Outstanding

    n/a
    		 10.99M

    Shares Change (YoY)

    n/a
    		 0.01%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 81.59%

    Shares Floating

    n/a
    		 10.54M

    Failed to Deliver (FTD) Shares

    n/a
    		 722

    FTD / Avg. Volume

    n/a
    		 0.32%

    Short Selling Information

    The latest short interest is 1.33M, so 12.11% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 1.33M

    Short % of Shares Out

    n/a
    		 12.11%

    Short % of Float

    n/a
    		 12.44%

    Short Ratio (days to cover)

    n/a
    		 6.04

    Valuation Ratios

    The PE ratio is 92.1 and the forward PE ratio is -9.92. Medifast's PEG ratio is -0.94.

    PE Ratio

    n/a
    		 92.1

    Forward PE

    n/a
    		 -9.92

    PS Ratio

    n/a
    		 0.32

    Forward PS

    n/a
    		 0.4

    PB Ratio

    n/a
    		 0.92

    P/FCF Ratio

    n/a
    		 11.31

    PEG Ratio

    n/a
    		 -0.94
    Financial Ratio History

    Enterprise Valuation

    Medifast has an Enterprise Value (EV) of 117.78M.

    EV / Sales

    n/a
    		 0.2

    EV / EBITDA

    n/a
    		 7.56

    EV / EBIT

    n/a
    		 4.81

    EV / FCF

    n/a
    		 6.92

    Financial Position

    The company has a current ratio of 3.34, with a Debt / Equity ratio of 0.08.

    Current Ratio

    n/a
    		 3.34

    Quick Ratio

    n/a
    		 2.68

    Debt / Equity

    n/a
    		 0.08

    Debt / EBITDA

    n/a
    		 1.03

    Debt / FCF

    n/a
    		 0.95

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is 1% and Return on Invested Capital is 0.7%.

    Return on Equity

    n/a
    		 1%

    Return on Assets

    n/a
    		 0.74%

    Return on Invested Capital

    n/a
    		 0.7%

    Revenue Per Employee

    n/a
    		 $1,195,363.1

    Profits Per Employee

    n/a
    		 $4,148.81

    Employee Count

    n/a
    		 504

    Asset Turnover

    n/a
    		 2.12

    Inventory Turnover

    n/a
    		 3.72

    Taxes

    Income Tax

    n/a
    		 1.7M

    Effective Tax Rate

    n/a
    		 44.78%

    Stock Price Statistics

    The stock price has increased by -32.23% in the last 52 weeks. The beta is 0.89, so Medifast's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.89

    52-Week Price Change

    n/a
    		 -32.23%

    50-Day Moving Average

    n/a
    		 13.04

    200-Day Moving Average

    n/a
    		 16.06

    Relative Strength Index (RSI)

    n/a
    		 52.82

    Average Volume (20 Days)

    n/a
    		 224,346

    Income Statement

    In the last 12 months, Medifast had revenue of 602.46M and earned 2.09M in profits. Earnings per share was 0.19.

    Revenue

    n/a
    		 602.46M

    Gross Profit

    n/a
    		 444.62M

    Operating Income

    n/a
    		 2.88M

    Net Income

    n/a
    		 2.09M

    EBITDA

    n/a
    		 15.59M

    EBIT

    n/a
    		 2.88M

    Earnings Per Share (EPS)

    n/a
    		 0.19
    Full Income Statement

    Balance Sheet

    The company has 90.93M in cash and 16.13M in debt, giving a net cash position of 74.8M.

    Cash & Cash Equivalents

    n/a
    		 90.93M

    Total Debt

    n/a
    		 16.13M

    Net Cash

    n/a
    		 74.8M

    Retained Earnings

    n/a
    		 176.78M

    Total Assets

    n/a
    		 280.01M

    Working Capital

    n/a
    		 152.93M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 24.48M and capital expenditures -7.45M, giving a free cash flow of 17.02M.

    Operating Cash Flow

    n/a
    		 24.48M

    Capital Expenditures

    n/a
    		 -7.45M

    Free Cash Flow

    n/a
    		 17.02M

    FCF Per Share

    n/a
    		 1.56
    Full Cash Flow Statement

    Margins

    Gross margin is 73.8%, with operating and profit margins of 0.48% and 0.35%.

    Gross Margin

    n/a
    		 73.8%

    Operating Margin

    n/a
    		 0.48%

    Pretax Margin

    n/a
    		 0.63%

    Profit Margin

    n/a
    		 0.35%

    EBITDA Margin

    n/a
    		 2.59%

    EBIT Margin

    n/a
    		 0.48%

    FCF Margin

    n/a
    		 2.83%

    Dividends & Yields

    MED pays an annual dividend of $8.23, which amounts to a dividend yield of 8.2%.

    Dividend Per Share

    n/a
    		 $8.23

    Dividend Yield

    n/a
    		 8.2%

    Dividend Growth (YoY)

    n/a
    		 0.61%

    Payout Ratio

    n/a
    		 -1285.94%

    Earnings Yield

    n/a
    		 1.09%

    FCF Yield

    n/a
    		 8.84%
    Dividend Details

    Analyst Forecast

    The average price target for MED is $16.5, which is 21.9% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $16.5

    Price Target Difference

    n/a
    		 21.9%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 $0.95

    Lynch Upside

    n/a
    		 -92.98%

    Graham Number

    n/a
    		 9.1

    Graham Upside

    n/a
    		 -32.79%

    Scores

    Altman Z-Score

    n/a
    		 4.74

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist